CNS Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
CNSP Nasdaq 2830 www.cnspharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline - Mar 11th, 2026 6:35 am
CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team - Mar 2nd, 2026 6:25 am
CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation - Feb 17th, 2026 6:25 am
CNS Pharmaceuticals Issues Letter to Shareholders - Jan 27th, 2026 7:00 am
CNS Pharmaceuticals Announces CEO Transition - Dec 17th, 2025 5:00 am
CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update - Nov 17th, 2025 6:35 am
CNS Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentation at the Society of NueroOncology (SNO) 30th Annual Meeting - Nov 10th, 2025 6:45 am
CNS Pharmaceuticals upgraded to Buy at Maxim on TPI-287 roadmap - Sep 13th, 2025 7:05 am
CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Sep 3rd, 2025 7:15 am
IBN Announces Latest Episode of The BioMedWire Podcast Featuring John Climaco, CEO of CNS Pharmaceuticals Inc. - Aug 27th, 2025 6:00 am
JTC Team Companies to Present in Webull Corporate Connect Webinar Series: Biotech/MedTech on August 19-21, 2025 - Aug 15th, 2025 8:00 am
CNS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Aug 15th, 2025 6:05 am
CNS Pharmaceuticals to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech - Aug 14th, 2025 7:15 am
CNS Pharmaceuticals to Participate in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference - Jul 22nd, 2025 6:45 am
JTC Team Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference Now Live - Jul 22nd, 2025 6:40 am
JTC Team Announces Participating Line Up for the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference - Jul 18th, 2025 9:00 am
CNS Pharmaceuticals Announces Reverse Stock Split - Jul 18th, 2025 6:00 am
CNS Pharmaceuticals Participates in Virtual Investor CEO Connect Segment - Jul 9th, 2025 7:32 am
CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment Discussing Glioblastoma Multiforme (GBM) and Lead Product Candidate TPI 287 - Jun 24th, 2025 7:15 am
CNS Pharmaceuticals' Chief Medical Officer, Sandra Silberman, MD, PhD to Present at the 2025 Brain Tumor Biotech Summit - Jun 5th, 2025 6:05 am